Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/TXG
icon
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

10X Genomics Inc (TXG) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

TXG trades at $76.60, up 5.39% today, with a bullish technical signal supported by moving averages and strong institutional interest. Recent earnings beats and a patent victory against Parse Biosciences (PRNewsWire, 2026-08-28) highlight operational momentum, though the stock trades above the consensus price target of $53.33. Revenue growth has been inconsistent, with 2025 revenue at $643 million but a net loss of $44 million, reflecting high R&D and SG&A costs amid expansion.
The outlook is mixed: bullish technicals and strategic collaborations (e.g., with Lunit, PRNewsWire 2026-09-10) support upside, but valuation metrics like EV/EBITDA of 333.81 and negative profitability margins pose risks. Investors face volatility from execution challenges and competitive pressures in genomics, with analyst sentiment divided (45% buy, 50% hold).
Read full analysis

Key Stats

  • Market Cap
    $9.98B
  • Volume
    2,884,568
  • Sector
    Health
  • 52W High
    $76.97
  • 52W Low
    $11.34
  • Typical Hold Time
    94 Days
  • Enterprise Value
    $9.51B
  • Div Yield
    -
  • Trading Activity
    5% Sell | 95% Buy
$76.6
52W Low: $11.34
29 Sep 2025
52W High: $76.97
17 Sep 2026

Track 10X Genomics Inc (TXG) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, 10X Genomics Inc has traded between a low of $11.34 and a high of $76.97, highlighting its annual price range. Buy and sell 10X Genomics Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Most Recent News

Content is generated by Aura AI

Three US-listed uranium juniors race to fill supply gap amid nuclear fuel demand surge

Three US-listed junior uranium miners—Uranium Energy, Denison Mines, and NexGen Energy—are positioned to benefit from the growing demand for nuclear fuel driven by new reactor builds and US policy support. Uranium Energy is the only one currently pro...

Market News
4 hours ago
24/7 Wall Street
Bullish
news icon
Three US-listed uranium juniors race to fill supply gap amid nuclear fuel demand surge

Goldman Sachs S&P 500 Premium Income ETF offers 8.21% yield despite Fed rate hikes, showing strong income growth and market leadership.

The Goldman Sachs S&P 500 Premium Income ETF (GPIX) remains attractive despite recent Federal Reserve rate hikes, thanks to its dynamic call overwrite strategy that adapts monthly. GPIX captures 85.7% of the S&P 500's total return while delivering an...

Market News
4 hours ago
Seeking Alpha
Bullish
news icon
Goldman Sachs S&P 500 Premium Income ETF offers 8.21% yield despite Fed rate hikes, showing strong income growth and market leadership.

Amgen outshines Merck in dividend growth and payout durability amid patent challenges.

Amgen and Merck both pay quarterly dividends and raise them annually, but Amgen offers a higher yield (2.6% vs. 2.29%) and has consistently raised dividends by about 6% annually. While Merck relies heavily on its Keytruda franchise, facing a looming ...

Market News
4 hours ago
24/7 Wall Street
Bullish
news icon
Amgen outshines Merck in dividend growth and payout durability amid patent challenges.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $9.98B
  • Volume
    2,884,568
  • Sector
    Health
  • 52W High
    $76.97
  • 52W Low
    $11.34
  • Typical Hold Time
    94 Days
  • Enterprise Value
    $9.51B
  • Div Yield
    -
  • Trading Activity
    5% Sell | 95% Buy
$76.6
52W Low: $11.34
29 Sep 2025
52W High: $76.97
17 Sep 2026

Track 10X Genomics Inc (TXG) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, 10X Genomics Inc has traded between a low of $11.34 and a high of $76.97, highlighting its annual price range. Buy and sell 10X Genomics Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!